Keybank National Association Eli Lilly & CO Transaction History

Keybank National Association

$23.9 Billion
Q1 2024

A detailed history of Keybank National Association transactions in Eli Lilly & CO stock. As of the latest transaction made, Keybank National Association holds 127,828 shares of LLY stock, worth $117 Million. This represents 0.42% of its overall portfolio holdings.

Number of Shares

127,828

Previous 105,089 21.64%

Holding current value

$117 Million

Previous $61.3 Million 62.34%

% of portfolio

0.42%

Previous 0.27%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 14, 2024	BUY	$592.2 - $792.28 $13.5 Million - $18 Million	22,739 Added 21.64%	127,828 $99.4 Million
Q4 2023 Feb 13, 2024	SELL	$525.19 - $619.13 $1.82 Million - $2.14 Million	-3,458 Reduced 3.19%	105,089 $61.3 Million
Q3 2023 Nov 08, 2023	BUY	$434.7 - $599.3 $734,208 - $1.01 Million	1,689 Added 1.58%	108,547 $58.3 Million
Q2 2023 Aug 01, 2023	BUY	$350.74 - $468.98 $585,034 - $782,258	1,668 Added 1.59%	106,858 $50.1 Million
Q1 2023 May 10, 2023	SELL	$310.63 - $364.82 $253,163 - $297,328	-815 Reduced 0.77%	105,190 $36.1 Million

Q4 2022 Jan 31, 2023	SELL	$321.55 - $374.67 $1.41 Million - $1.64 Million	-4,372 Reduced 3.96%	106,005 $38.8 Million
Q3 2022 Oct 27, 2022	BUY	$296.48 - $337.87 $1 Million - $1.15 Million	3,389 Added 3.17%	110,377 $35.7 Million
Q2 2022 Aug 08, 2022	SELL	$278.73 - $327.27 $428,686 - $503,341	-1,538 Reduced 1.42%	106,988 $34.7 Million
Q1 2022 Apr 28, 2022	SELL	$234.69 - $291.66 $460,461 - $572,236	-1,962 Reduced 1.78%	108,526 $31.1 Million
Q4 2021 Feb 07, 2022	BUY	$224.85 - $279.04 $20,686 - $25,671	92 Added 0.08%	110,488 $30.5 Million
Q3 2021 Nov 08, 2021	BUY	$221.6 - $272.71 $334,837 - $412,064	1,511 Added 1.39%	110,396 $25.5 Million
Q2 2021 Aug 12, 2021	SELL	$180.55 - $233.54 $580,287 - $750,597	-3,214 Reduced 2.87%	108,885 $25 Million
Q1 2021 May 07, 2021	SELL	$164.32 - $212.72 $409,649 - $530,310	-2,493 Reduced 2.18%	112,099 $20.9 Million
Q4 2020 Feb 09, 2021	SELL	$130.46 - $172.63 $730,445 - $966,555	-5,599 Reduced 4.66%	114,592 $19.3 Million
Q3 2020 Oct 29, 2020	BUY	$146.22 - $169.13 $391,284 - $452,591	2,676 Added 2.28%	120,191 $17.8 Million
Q2 2020 Aug 10, 2020	SELL	$136.42 - $164.18 $368,333 - $443,286	-2,700 Reduced 2.25%	117,515 $19.3 Million
Q1 2020 May 13, 2020	SELL	$119.05 - $147.35 $211,075 - $261,251	-1,773 Reduced 1.45%	120,215 $16.7 Million
Q4 2019 Feb 05, 2020	SELL	$106.92 - $132.43 $242,601 - $300,483	-2,269 Reduced 1.83%	121,988 $16 Million
Q3 2019 Nov 04, 2019	SELL	$106.79 - $116.16 $1.01 Million - $1.1 Million	-9,480 Reduced 7.09%	124,257 $13.9 Million
Q2 2019 Aug 01, 2019	SELL	$110.79 - $129.32 $481,160 - $561,636	-4,343 Reduced 3.15%	133,737 $14.8 Million
Q1 2019 May 08, 2019	SELL	$111.31 - $131.02 $574,136 - $675,801	-5,158 Reduced 3.6%	138,080 $17.9 Million
Q4 2018 Jan 30, 2019	SELL	$105.9 - $118.64 $355,400 - $398,155	-3,356 Reduced 2.29%	143,238 $16.6 Million
Q3 2018 Nov 08, 2018	SELL	$85.86 - $107.31 $755,739 - $944,542	-8,802 Reduced 5.66%	146,594 $15.7 Million
Q2 2018 Aug 08, 2018	SELL	$75.7 - $86.88 $1.15 Million - $1.32 Million	-15,136 Reduced 8.88%	155,396 $13.3 Million
Q1 2018 May 15, 2018	SELL	$74.21 - $87.6 $1.04 Million - $1.23 Million	-14,076 Reduced 7.62%	170,532 $13.2 Million
Q4 2017 Feb 08, 2018	SELL	$81.94 - $87.89 $2.53 Million - $2.72 Million	-30,900 Reduced 14.34%	184,608 $15.6 Million
Q3 2017 Nov 02, 2017	SELL	$77.07 - $85.54 $49,556 - $55,002	-643 Reduced 0.3%	215,508 $18.4 Million
Q2 2017 May 14, 2018	BUY	N/A	47,963 Added 28.52%	216,151 $17.8 Million
Q1 2017 May 14, 2018	SELL	N/A	-9,232 Reduced 5.2%	168,188 $14.1 Million
Q4 2016 May 14, 2018	BUY	N/A	177,420	177,420 $13 Million

Others Institutions Holding LLY

# of Institutions

3,725

Shares Held

738M

Call Options Held

7.09M

Put Options Held

7.24M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $869B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Keybank National Association, based on Form 13F filings with the SEC.

News

Stay updated on Keybank National Association with notifications on news.

Account

Keybank National Association Eli Lilly & CO Transaction History